https://www.selleckchem.com/pr....oducts/sar131675.htm
The predictive immune model will enable patients with HCC to be more accurately managed in immunotherapy. The predictive immune model will enable patients with HCC to be more accurately managed in immunotherapy. Conventional immunotherapy for glioma is not only expensive but also demonstrates less-than-desired clinical efficacy. In this study, we evaluated the immunotherapeutic efficacy of a tumor cell lysate-based hybrid glioma vaccine developed using a molecular-based approach. First, the ability of the autologous (9L-cell lysate) a
Like
Comment
Share
